Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 73 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
F Hoffmann-La Roche Genentech NIH
Grant: P30 CA016672
NIH
Grant: CA016672
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
Influential Citations
1
Fields of Study
Keywords
Sustainable Development Goals